[1]
|
Hoftberger, R. and Lassmann, H. (2017) Inflammatory Demyelinating Diseases of the Central Nervous System. In: Handbook of Clinical Neurology, Vol. 145, Elsevier, Amsterdam, 263-283.
https://doi.org/10.1016/B978-0-12-802395-2.00019-5
|
[2]
|
Ajmi, H., Jammeli, N., Hassayoun, S., et al. (2021) Acute Disseminated Encephalomyelitis: A Retrospective Study of 20 Children in a Pediatrics Department in Tunisia. Archives de Pédiatrie, 28, 638-646.
https://doi.org/10.1016/j.arcped.2021.09.027
|
[3]
|
Yao, Y., Xu, Y., Ren, H., et al. (2019) Acute Epileptic Seizures in Myelin Oligodendrocyte Glycoprotein Encephalomyelitis and Neuromyelitis Optica Spectrum Disorder: A Comparative Cohort Study. Multiple Sclerosis and Related Disorders, 27, 281-288. https://doi.org/10.1016/j.msard.2018.11.007
|
[4]
|
Fujimori, J., Takai, Y., Nakashima, I., et al. (2017) Bilateral Frontal Cortex Encephalitis and Paraparesis in a Patient with Anti-MOG Antibodies. Journal of Neurology, Neurosurgery & Psychiatry, 88, 534-536.
https://doi.org/10.1136/jnnp-2016-315094
|
[5]
|
Wegener-Panzer, A., Cleaveland, R., Wendel, E., et al. (2020) Clinical and Imaging Features of Children with Autoimmune Encephalitis and MOG Antibodies. Neurology—Neuroimmunology Neuroinflammation, 7, e731.
https://doi.org/10.1212/NXI.0000000000000731
|
[6]
|
Baumann, M., Sahin, K., Lechner, C., et al. (2015) Clinical and Neuroradiological Differences of Paediatric Acute Disseminating Encephalomyelitis with and without Antibodies to the Myelin Oligodendrocyte Glycoprotein. Journal of Neurology, Neurosurgery & Psychiatry, 86, 265-272. https://doi.org/10.1136/jnnp-2014-308346
|
[7]
|
Ramanathan, S., Mohammad, S., Tantsis, E., et al. (2018) Clinical Course, Therapeutic Responses and Outcomes in Relapsing MOG Antibody-Associated Demyelination. Journal of Neurology, Neurosurgery & Psychiatry, 89, 127-137.
https://doi.org/10.1136/jnnp-2017-316880
|
[8]
|
Ding, J., Li, X. and Tian, Z. (2021) Clinical Features of Coexisting Anti-NMDAR and MOG Antibody-Associated Encephalitis: A Systematic Review and Meta-Analysis. Frontiers in Neurology, 12, Article ID: 711376.
https://doi.org/10.3389/fneur.2021.711376
|
[9]
|
Fan, S., Xu, Y., Ren, H., et al. (2018) Comparison of Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Disease and AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) When They Co-Exist with Anti-NMDA (N-methyl-D-aspartate) Receptor Encephalitis. Multiple Sclerosis and Related Disorders, 20, 144-152.
https://doi.org/10.1016/j.msard.2018.01.007
|
[10]
|
Calabrese, M., Grossi, P., Favaretto, A., et al. (2011) Cortical Pathology in Multiple Sclerosis Patients with Epilepsy: A 3 Year Longitudinal Study. Journal of Neurology, Neurosurgery & Psychiatry, 83, 49-54.
https://doi.org/10.1136/jnnp-2011-300414
|
[11]
|
Hacohen, Y., Wong, Y.Y., Lechner, C., et al. (2018) Disease Course and Treatment Responses in Children with Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurology, 75, 478.
https://doi.org/10.1001/jamaneurol.2017.4601
|
[12]
|
Rossor, T., Benetou, C., Wright, S., et al. (2020) Early Predictors of Epilepsy and Subsequent Relapse in Children with Acute Disseminated Encephalomyelitis. Multiple Sclerosis Journal, 26, 333-342.
https://doi.org/10.1177/1352458518823486
|
[13]
|
Ogawa, R., Nakashima, I., Takahashi, T., et al. (2017) MOG Antibody-Positive, Benign, Unilateral, Cerebral Cortical Encephalitis with Epilepsy. Neurology: Neuroimmunology & Neuroinflammation, 4, e322.
https://doi.org/10.1212/NXI.0000000000000322
|
[14]
|
Shu, H., Ding, M., Shang, P., et al. (2022) Myelin Oligodendrocyte Glycoprotein Antibody Associated Cerebral Cortical Encephalitis: Case Reports and Review of Literature. Frontiers in Human Neuroscience, 15, Article ID: 782490.
https://doi.org/10.3389/fnhum.2021.782490
|
[15]
|
Mahamud, Z., Burman, J. and Zelano, J. (2018) Risk of Epilepsy after a Single Seizure in Multiple Sclerosis. European Journal of Neurology, 25, 854-860. https://doi.org/10.1111/ene.13618
|
[16]
|
Zhong, X., Zhou, Y., Chang, Y., et al. (2019) Seizure and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis in a Retrospective Cohort of Chinese Patients. Frontiers in Neurology, 10, Article No. 415.
https://doi.org/10.3389/fneur.2019.00415
|
[17]
|
Etemadifar, M., Sabeti, F., Khorvash, R., et al. (2021) Seizure Incidence among Neuromyelitis Optica Spectrum Disorder Patients. Revue Neurologique, 177, 655-659. https://doi.org/10.1016/j.neurol.2020.08.011
|
[18]
|
Hamid, S.H.M., Whittam, D., Saviour, M., et al. (2018) Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease. JAMA Neurology, 75, 65. https://doi.org/10.1001/jamaneurol.2017.3196
|
[19]
|
Langenbruch, L., Krämer, J., Güler, S., et al. (2019) Seizures and Epilepsy in Multiple Sclerosis: Epidemiology and Prognosis in a Large Tertiary Referral Center. Journal of Neurology, 266, 1789-1795.
https://doi.org/10.1007/s00415-019-09332-x
|
[20]
|
Thomas, F., Matteo, G., Silvia, S., et al. (2020) Seizures and Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies: Two Paradigmatic Cases and a Review of the Literature. Multiple Sclerosis and Related Disorders, 41, Article ID: 102011. https://doi.org/10.1016/j.msard.2020.102011
|
[21]
|
Tao, R., Qin, C., Chen, M., et al. (2020) Unilateral Cerebral Cortical Encephalitis with Epilepsy: A Possible Special Phenotype of MOG Antibody-Associated Disorders. International Journal of Neuroscience, 130, 1161-1165.
https://doi.org/10.1080/00207454.2020.1720676
|
[22]
|
孙红, 谭建敏, 刘静临, 等. 儿童髓鞘少突胶质细胞糖蛋白抗体相关脱髓鞘病57例临床特征及预后分析[J]. 临床儿科杂志, 2020, 38(11): 824-830.
|
[23]
|
Ramanathan, S., O’Grady, G.L., Malone, S., et al. (2018) Isolated Seizures during the First Episode of Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Demyelination in Children. Developmental Medicine & Child Neurology, 61, 610-614. https://doi.org/10.1111/dmcn.14032
|
[24]
|
Taraschenko, O. and Zabad, R. (2019) Overlapping Demyelinating Syndrome and Anti-N-methyl-d-aspartate Receptor Encephalitis with Seizures. Epilepsy & Behavior Reports, 12, Article ID: 100338.
https://doi.org/10.1016/j.ebr.2019.100338
|
[25]
|
Jarius, S., Paul, F., Aktas, O., et al. (2018) MOG Encephalomyelitis: International Recommendations on Diagnosis and Antibody Testing. Journal of Neuroinflammation, 15, 134. https://doi.org/10.1186/s12974-018-1144-2
|
[26]
|
Hacohen, Y., Absoud, M., Deiva, K., et al. (2015) Myelin Oligodendrocyte Glycoprotein Antibodies Are Associated with a Non-MS Course in Children. Neurology: Neuroimmunology & Neuroinflammation, 2, e81.
https://doi.org/10.1212/NXI.0000000000000081
|
[27]
|
de Mol, C.L., Wong, Y., van Pelt, E.D., et al. (2020) The Clinical Spectrum and Incidence of Anti-MOG-Associated Acquired Demyelinating Syndromes in Children and Adults. Multiple Sclerosis Journal, 26, 806-814.
https://doi.org/10.1177/1352458519845112
|
[28]
|
Mclaughlin, K.A., Chitnis, T., Newcombe, J., et al. (2009) Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis. Journal of Immunology, 183, 4067-4076.
https://doi.org/10.4049/jimmunol.0801888
|
[29]
|
Narayan, R.N., Wang, C., Sguigna, P., et al. (2019) A Typical Anti-MOG Syndrome with Aseptic Meningoencephalitis and Pseudotumor Cerebri-Like Presentations. Multiple Sclerosis and Related Disorders, 27, 30-33.
https://doi.org/10.1016/j.msard.2018.10.003
|
[30]
|
Jurynczyk, M., Messina, S., Woodhall, M.R., et al. (2017) Clinical Presentation and Prognosis in MOG-Antibody Disease: A UK Study. Brain, 140, 3128-3138. https://doi.org/10.1093/brain/awx276
|
[31]
|
Whittam, D.H., Karthikeayan, V., Gibbons, E., et al. (2020) Treatment of MOG Antibody Associated Disorders: Results of an International Survey. Journal of Neurology, 267, 3565-3577. https://doi.org/10.1007/s00415-020-10026-y
|
[32]
|
杨赛, 廖红梅, 吴丽文, 等. 儿童MOG抗体病复发危险因素分析[J]. 临床儿科杂志, 2021, 39(12): 916-922.
|
[33]
|
Reindl, M. and Waters, P. (2019) Myelin Oligodendrocyte Glycoprotein Antibodies in Neurological Disease. Nature Reviews. Neurology, 15, 89-102. https://doi.org/10.1038/s41582-018-0112-x
|
[34]
|
Narayan, R., Simpson, A., Fritsche, K., et al. (2018) MOG Antibody Disease: A Review of MOG Antibody Seropositive Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis and Related Disorders, 25, 66-72.
https://doi.org/10.1016/j.msard.2018.07.025
|
[35]
|
Thompson, A.J., Baranzini, S.E., Geurts, J., et al. (2018) Multiple Sclerosis. The Lancet, 391, 1622-1636.
https://doi.org/10.1016/S0140-6736(18)30481-1
|
[36]
|
Fujihara, K., Misu, T., Nakashima, I., et al. (2012) Neuromyelitis Optica Should Be Classified as an Astrocytopathic Disease Rather than a Demyelinating Disease. Clinical & Experimental Neuroimmunology, 3, 58-73.
https://doi.org/10.1111/j.1759-1961.2012.00030.x
|